what GOP-1 does.

And you must remember now that GOP-1 is just at the beginning of a fantastic exploding trajectory.

So the first version of GOP-1s were just targeting one receptor.

The ones that we see now, they're targeting three receptors.

And I don't see it stopping there, right? So what we see is this Swiss army knife of attacking what's called the metabolic syndrome, which is not just obesity, it's diabetes, it's certain types of cancers, it's psoriasis, sleep apnea, cardiovascular diseases, what have you.

So for the healthcare sector out there, this is the magic pill that they can bring to people and radically lower their overall cost for handling all the other things, not just obesity and so which means that the food sector might see this as an obesity pill and analyze it as such but the fact is that they would be more effective through the back door by people taking this for other reasons And when I look at this, it's like, yeah, do invest in the healthy stuff for the future, because you don't want to be stuffed with things that are a menace of snacks or sugary drinks or even alcohol.

Yeah, yeah,

yeah.